Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs nearly 6000 people in over 80 countries.
Post : Sr. Officers / Officers / Jr. Officer - Production
source https://www.pharmatutor.org/content/january-2020/walk-in-interview-in-production-at-glenmark
No comments:
Post a Comment